In comparison to healthy controls, pretreatment ITP patients had higher CD4/CD8 ratios, lower levels of NK cells and CD4+CD25+CD127low Tregs, and lower levels of NK cells. This evidence concerns the gene CD8A and autoimmune thrombocytopenic purpura.